Team:WashU StLouis/Parts
From 2014.igem.org
(Difference between revisions)
(3 intermediate revisions not shown) | |||
Line 11: | Line 11: | ||
<table id="menu" width=100%" cellspacing="0" height="500px"> | <table id="menu" width=100%" cellspacing="0" height="500px"> | ||
<tr> | <tr> | ||
- | <td width="600px" align="center" bgColor="# | + | <td width="600px" align="center" bgColor="#FFF" > |
<!--Parts content --> | <!--Parts content --> | ||
- | <table id="general" | + | <table style="width: 100%; height: 432px;" id="general" cellpadding="5" |
- | + | cellspacing="0"> | |
- | < | + | <tbody> |
- | <tr><td | + | <tr> |
- | < | + | <td style="text-align: center;" colspan="3" rowspan="1"> |
- | + | <h1>Biobrick Cloning</h1> | |
+ | </td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td | + | <td style="width: 40%; vertical-align: top;"> |
- | < | + | <div style="text-align: center;"> <span |
- | + | style="font-weight: bold;">Light Regulation Group - Benjamin Huang</span><br> | |
- | + | </div> | |
- | < | + | <div style="text-align: justify;">Cloning the biobricks was more |
- | < | + | difficult than expected. Ben tried to do digestion/ligation using the |
- | < | + | restriction enzymes using the PSB1C3 backbone from <a href=http://parts.igem.org/Part:BBa_K1017726>BBa_K1017726</a>, but |
- | + | transformation into <span style="font-style: italic;">E. coli</span> | |
- | < | + | strain DH10B yielded low efficiency with minimal number of colonies. He |
- | + | ran sequencing PCR with primers that bound to both the backbone and the | |
- | < | + | target part. He found the prefix but not the suffix.<br> |
- | + | <br> | |
- | + | Ben and Cheryl tried different sequencing primers that bound to sites | |
- | + | on the genes instead, and re-ran sequencing PCR to no avail. Next, they | |
- | < | + | tried religating using higher molar ratios 3:1 vector to insert, and |
- | + | the sequencing PCR ran into the same issue.<br> | |
- | < | + | <br> |
- | + | We then got a new purified backbone from the distribution well from | |
- | </ | + | caroline and used that to clone. We also used Andrew's <a |
+ | href="https://2014.igem.org/Team:WashU_StLouis/Protocol#17">CPEC</a> | ||
+ | protocol to clone both the hybrid and normal part. We weren't able to | ||
+ | clone the positive control because for the protocol you need 15-20 bp | ||
+ | overlaps and the primers we had on hand did not allow for that. Also | ||
+ | there was a very similar part on the parts registry so there was no use | ||
+ | sending a part that essentially had the same Ptet and EYFP. <br> | ||
+ | <br> | ||
+ | Using PCR purified products, the CPEC cloning had much higher | ||
+ | efficiency than digestion/ligation. We ran colony PCR on the colonies, | ||
+ | checking for both the prefix and suffix, and the colonies that came | ||
+ | from the CPEC had the right bands. We sent in the sequences for | ||
+ | sequence verification and successfully sent in 2 biobrick parts.<br> | ||
+ | </div> | ||
+ | <br> | ||
+ | <br> | ||
</td> | </td> | ||
- | + | <td style="width: 20%;"> <img style="width: 100%; height: 400px;" | |
- | <td > < | + | alt="Biobrick Submission" |
- | + | src="https://static.igem.org/mediawiki/2014/f/f9/WashU_biobrick.jpg"><br> | |
- | + | <div style="text-align: center;">Biobrick Submission: 10/8/14<br> | |
- | + | </div> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | < | + | |
- | + | ||
- | </ | + | |
</td> | </td> | ||
+ | <td style="vertical-align: top; text-align: justify; width: 40%;"> | ||
+ | <div style="text-align: center; font-weight: bold;">Nitrogenase | ||
+ | Group - Caroline Focht<br> | ||
+ | </div> | ||
+ | The original idea was to break the nif cluster from <i>Cyanothece </i>sp. | ||
+ | 51142 into six different parts since the entire cluster is upwards of | ||
+ | 35 kb. Primers were designed, and the desired fragments were produced | ||
+ | via PCR. After running a gel to confirm the products, it was observed | ||
+ | that some of the PCR reactions had not produced any of the desired | ||
+ | fragments. <br> | ||
+ | <br> | ||
+ | Using a temperature gradient and DMSO, all of the fragments | ||
+ | were eventually obtained. The BioBrick backbone pSC1B3 was isolated | ||
+ | from an existing BioBrick part taken from the distribution plate using | ||
+ | PCR and the codes for the BioBrick prefix and suffix as primers. This | ||
+ | successfully produced the pSC1B3 plasmid, into which the six different | ||
+ | fragments were inserted using Andrew Ng’s <a | ||
+ | href="https://2014.igem.org/Team:WashU_StLouis/Protocol#17">CPEC</a> | ||
+ | protocol. <br> | ||
+ | <br> | ||
+ | The now | ||
+ | complete plasmids, backbone plus insert, were transformed into the <i>E. | ||
+ | coli</i> strain XL1 Blue and plated on LB plates. The <i>E. coli</i> were | ||
+ | cultured | ||
+ | overnight, and four cultures from each plate were selected for colony | ||
+ | PCR the next morning. The colony PCR indicated some positive results, | ||
+ | and the plasmids were extracted from those strains, digested with the | ||
+ | enzymes XbaI and SpeI, and confirmed with a gel. <br> | ||
+ | <br> | ||
+ | Only two of the | ||
+ | BioBricks showed correct bands from the enzyme digest. After all of | ||
+ | this was complete, it was discovered that all of our prospective | ||
+ | BioBricks including the two successful ones, all contained one or more | ||
+ | illegal restriction sites, thus invalidating their submission.</td> | ||
</tr> | </tr> | ||
- | + | <tr align="center"> | |
- | + | <td colspan="3" height="15"> Submitted Biobricks:<br> | |
- | <tr> <td colspan="3" | + | BBa_K1385000: CpcG2 promoter expressing TetR<br> |
- | + | BBa_K1385001: Hybrid CpcG2 promoter expressing TetR<br> | |
- | <tr><td colspan="3" > <h3> Parts Table</h3></td></tr> | + | </td> |
- | + | </tr> | |
- | + | <tr> | |
- | <tr><td | + | <td colspan="3"> |
- | Any parts your team has created will appear in this table below:</td></tr> | + | <h3> Parts Table</h3> |
- | + | </td> | |
+ | </tr> | ||
+ | <tr> | ||
+ | <td colspan="3" valign="top" width="45%">Any parts your team has | ||
+ | created will appear in this table below:</td> | ||
+ | </tr> | ||
+ | </tbody> | ||
</table> | </table> | ||
</html> | </html> |
Latest revision as of 18:41, 16 October 2014
|